Swedbank’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
AIM
ECSS
EB
CPC
AIM
AAMU
AAIS
SIC
BCAM
Swedbank's DGX Position: Q2 2026 in Review
Swedbank increased its Quest Diagnostics (DGX) stake by 4% in Q2 2026, buying an estimated $745K and bringing the position to 97,588 shares worth $20.7M. The position accounts for 0.02% of the portfolio, ranked #394.
Swedbank first reported a position in DGX in Q1 2021 and has held it in 22 quarters since. The position peaked at $24.4M in Q3 2021. 380 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Swedbank held 97,588 shares of Quest Diagnostics worth $20.7M as of Q2 2026.
- Swedbank bought 3,794 Quest Diagnostics shares in Q2 2026, an estimated $745K.
- Quest Diagnostics made up 0.02% of Swedbank's portfolio in Q2 2026, its #394 holding.
- Swedbank first reported a position in Quest Diagnostics in Q1 2021 and has held it in 22 quarters since.
- Swedbank's Quest Diagnostics position peaked at $24.4M in Q3 2021.
- 380 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Swedbank's 13F filing for Q2 2026, filed 15 Jul 2026.